Page 1

Renub Research www.renub.com Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis

Published: December, 2012 Copyright © 2012 Renub Research – All Rights Reserved


Pediatric Vaccines Market Analysis Worldwide pediatric vaccine market has been growing rapidly over the last five years as it has doubled its market share in 2011 compared to 2005. The worldwide pediatrics vaccine market is expected to be more than US$ 23 Billion by 2015 growing with a single digit CAGR during 2012 – 2015. This incremental growth has been due to blockbuster vaccines (Prevnar7, Prevnar 13, Rotarix and Rotateq) sales in Billion of US$ which made a significant contribution. It is predicted that Pediatric proprietary vaccines will lead the segment with little less than 60% market share by 2015.The combinations & boosters and enhanced pediatric vaccines market are expected to show stagnant growth in future due to lower margins and the mature nature of these markets. Pneumococcal, DTP and Varicella together all these three vaccines control 55% of the market share in 2011. In number of cases Polio, Haemophiilus Influenzae Type B (HIB) and MMR cases have shown decline continuously from the year 2001 till 2011. Polio remains endemic merely in three countries and the good news is that India has not reported a single case from the past two years and on the verge of being called a polio free country. DTP are the most utilized vaccines in the pediatric vaccines market which contributed less than 10,000 Million doses in 2011. Pediatric Hepatitis and Polio vaccines are also mostly used vaccines which consumed more than 6,000 Million doses in 2011. In case of Rotavirus vaccine although the price of Rotavirus vaccine has declined but still its present prices are expensive than other pediatric vaccines. However despite all the impediments pediatric vaccines industry is expected to remain highly active in the future, fueled by the encouragement and financing from governments and other health organizations. Renub Research report titled "Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis� talks about the pediatric vaccines. The report provides information on all the Nine (9) Pediatric Vaccines Market, Doses, Immunization and Number of Cases by region in the world. This report covers in detail all aspects of past, present and future scenario. This report provides market landscape and market share information of the Pediatric Combinations & Booster, Pediatric Enhanced Combination and Pediatric Proprietary

Š Renub Research

Page 2 of 18


Vaccines Market. The report also entails major factors driving the pediatric vaccine market and challenges of pediatric vaccine market. Pediatric Vaccines Covered in this Report are as follows: Measles, Mumps & Rubella (MMR) Vaccines, Haemophilus Influenzae Type B (HIB) Vaccines, Polio Vaccines, Diphtheria, Tetanus & Pertussis (Combos) Vaccines, Pneumococcal Vaccines Rotavirus Vaccines, Hepatitis Pediatric Vaccines, Varicella/Chicken Pox Vaccines and Other Pediatric Vaccines All the Pediatric Vaccines in this Report have been Studied from Four View Points: 

Number of Cases Reported for all 9 Pediatric Diseases by Region from 2001 to 2011

Number of Doses Reported and Forecast for all 9 Pediatric Vaccine from 2005 to 2015

Immunization Coverage for all 9 Pediatric Vaccines and Forecast from 2005 to 2015

Market Size for all 9 Pediatric Vaccines and Forecast from 2005 to 2015

Key Topics Covered in the Report 

Worldwide – Pediatric Vaccines Market and Forecast (2006 - 2015)

Worldwide – Pediatric Vaccines Market Share and Forecast (Sector wise) (2005 - 2015)

Worldwide – Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 - 2015)

By Sector (All 9) – Pediatric Vaccines Market and Forecast (2005 - 2015)

By Region - Pediatric Disease Cases (2001 – 2011)

Pediatric Vaccines Doses and Forecast (2005 – 2015)

Pediatric Vaccines Immunization Coverage and Forecast (2005 - 2015)

All 9 Pediatric Vaccines Market and Forecast (2005 - 2015)

Growth Drivers of Pediatric Vaccines Market

Challenges of Pediatric Vaccines Market

© Renub Research

Page 3 of 18


Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts. Secondary sources information and data has been collected from various printable and nonprintable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.

Š Renub Research

Page 4 of 18


About Us Renub Research

is a leading Market Research and Information Analysis Company with

centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others. Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets.

For more information on us or to view any of our sample work you can mail us at info@renub.com

Š Renub Research

Page 5 of 18


Published By

Renub Research A–116B, Sector–27 Noida – 201301 Phone: +91-120-421-9822, 254-5750 (India) +1-678-302-0700 (USA) Fax : +91-120-424-9780 Email: info@renub.com www.renub.com

© Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis Renub Research, 2012 Edition 1.0 All rights reserved. This publication is protected by copyright. No part of it may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic mechanical, photocopying, recording or otherwise without the prior written permission of the publishers

© Renub Research

Page 6 of 18


Table of Contents 1.

Executive Summary

2.

Worldwide Pediatric Vaccines Market and Forecast (2006 – 2015)

3.

Worldwide – Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 – 2015)

4.

Worldwide – Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 – 2015)

5.

By Sector – Pediatric Vaccines Market and Forecast (2005 – 2015)

6.

5.1

Worldwide – Pediatric Combinations & Boosters Vaccines Market

5.2

Worldwide – Pediatric Enhanced Combinations Vaccines Market

5.3

Worldwide – Pediatric Proprietary Vaccines Market

Major Pediatric Vaccines Cases, Doses, Immunization Coverage, Market and Forecast 6.1

Measles, Mumps & Rubella (MMR) Vaccines and Forecast (2005 – 2015)

6.1.1

Number of Measles, Mumps & Rubella Cases (2001 – 2011)

6.1.2

Number of Measles, Mumps & Rubella (MMR) Vaccines Doses

6.1.3

Immunization Coverage of Measles, Mumps & Rubella (MMR) Vaccines

6.1.4

Market Size of Measles, Mumps & Rubella (MMR) Vaccines

6.2

Haemophilus Influenzae Type B (HIB) Vaccines and Forecast (2005 – 2015)

6.2.1

Number of Haemophilus Influenzae Type B (HIB) Meningitis Cases (2001 – 2011)

6.2.2

Number of Haemophilus Influenzae Type B (HIB) Vaccines Doses

6.2.3

Immunization Coverage of Haemophilus Influenzae Type B (HIB) Vaccines

6.2.4

Market Size of Haemophilus Influenzae Type B (HIB) Vaccines

6.3

Polio Vaccines and Forecast (2005 – 2015)

6.3.1

Number of Polio Cases (2001 – 2011)

6.3.2

Number of Polio Vaccines Doses

6.3.3

Immunization Coverage of Polio Vaccines

6.3.4

Market Size of Polio Vaccines

6.4

Diphtheria, Tetanus & Pertussis (Combos) Vaccines and Forecast (2005 – 2015)

6.4.1

Number of Diphtheria, Tetanus & Pertussis (DTP) Cases (2001 – 2011)

6.4.2

Number of Diphtheria, Tetanus & Pertusis (DTP) Vaccines Doses

6.4.3

Immunization Coverage of Diphtheria, Tetanus & Pertusis (DTP) Vaccines

6.4.4

Market Size of Diphtheria, Tetanus & Pertussis (Combos) Vaccines

6.5

Pneumococcal Vaccines and Forecast (2005 – 2015)

© Renub Research

Page 7 of 18


6.5.1

Number of Pneumococcal Cases (2000)

6.5.2

Number of Pneumococcal Vaccines Doses

6.5.3

Immunization Coverage of Pneumococcal Vaccines

6.5.4

Market Size of Pneumococcal Vaccines

6.6

Rotavirus Vaccine and Forecast (2006 – 2015)

6.6.1

Number of Rotavirus Cases (2008 & 2009)

6.6.2

Number of Rotavirus Vaccines Doses

6.6.3

Immunization Coverage of Rotavirus Vaccines

6.6.4

Market Size of Rotavirus Vaccine

6.7

Hepatitis Pediatric Vaccines and Forecast (2005 – 2015)

6.7.1

Number of Hepatitis Pediatric Vaccines Doses

6.7.2

Immunization Coverage of Hepatitis Pediatric Vaccines

6.7.3

Market Size of Hepatitis Pediatric Vaccines

6.8

Varicella/Chicken Pox Vaccines and Forecast (2005 – 2015)

6.8.1

Number of Varicella/Chicken Pox Vaccines Doses

6.8.2

Market Size of Varicella/Chicken Pox Vaccines

6.9

Other Pediatric Vaccines and Forecast (2005 – 2015)

6.9.1 7.

Market Size of Other Pediatric Vaccines

Growth Drivers of Pediatric Vaccines Market 7.1

Reduced Price on Rotavirus Vaccines: Enough to Facilitate Growth but More Still Needs To Be

Done Error! Bookmark not defined. 7.1.1

Rotavirus Vaccine Introduction

7.1.2

Financial Challenges

7.1.3

Cost Effective

7.1.4

Future Steps

7.1.5

Conclusion

7.2

7.2.1

The Partnership Model

7.2.2

The Business Model

7.3 8.

GAVI Model Increases Vaccine Manufacturers

WHO Global Vaccine Action Plan (2011 - 2020)

Challenges of Pediatric Vaccine Market 8.1

Roadblocks in Expanding Access to Newer Pediatric Vaccines

8.2

Impediment in Pediatric Vaccine Research & Development

© Renub Research

Page 8 of 18


8.3

Barriers to New Entrants in the Pediatric Vaccines Market

Š Renub Research

Page 9 of 18


List of Figures Figure 2-1: Worldwide – Pediatric Vaccines Market (Million US$), 2006 – 2011 Figure 2-2: Worldwide – Forecast for Pediatric Vaccines Market (Million US$), 2012 – 2015 Figure 3-1: Worldwide (Sector wise) – Pediatric Vaccines Market Share (Percent), 2005 – 2011 Figure 3-2: Worldwide (Sector wise) – Forecast for Pediatric Vaccines Market Share (Percent), 2012 – 2015 Figure 5-1: Worldwide – Pediatric Combinations & Boosters Vaccines Market (Million US$), 2005 – 2011 Figure 5-2: Worldwide – Forecast for Pediatric Combinations & Boosters Vaccines Market (Million US$), 2012 – 2015 Figure 5-3: Worldwide – Pediatric Enhanced Combinations Vaccines Market (Million US$), 2005 – 2011 Figure 5-4: Worldwide – Forecast for Pediatric Enhanced Combinations Vaccines Market (Million US$), 2012 – 2015 Figure 5-5: Worldwide – Pediatric Proprietary Vaccines Market (Million US$), 2005 – 2011 Figure 5-6: Worldwide – Forecast for Pediatric Proprietary Vaccines Market (Million US$), 2012 – 2015 Figure 6-1: Worldwide – Number of MMR Vaccines Doses (Million Doses), 2005 – 2011 Figure 6-2: Worldwide – Forecast for Number of MMR Vaccines Doses (Million Doses), 2012 – 2015 Figure 6-3: Worldwide – Immunization Coverage of MMR Vaccines Doses (Million Doses), 2005 – 2011 Figure 6-4: Worldwide – Forecast for Immunization Coverage of MMR Vaccines Doses (Million Doses), 2012 – 2015 Figure 6-5: Worldwide – Measles, Mumps & Rubella Vaccines Market (Million US$), 2005 – 2011 Figure 6-6: Worldwide – Forecast for Measles, Mumps & Rubella Vaccines Market (Million US$), 2012 – 2015 Figure 6-7: Worldwide – Haemophilus Influenzae Type B Vaccine Introduction in High & Low-Income Countries, 1980 – 2010 Figure 6-8: Worldwide – Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2005 – 2011 Figure 6-9: Worldwide – Forecast for Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2012 – 2015 Figure 6-10: Worldwide – Immunization Coverage of Haemophilus Influenzae Type B Vaccines (Million Doses), 2005 – 2011 Figure 6-11: Worldwide – Forecast for Immunization Coverage of Haemophilus Influenzae Type B Vaccines (Million Doses), 2012 – 2015 Figure 6-12: Worldwide – Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2005 – 2011 Figure 6-13: Worldwide – Forecast for Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2012 – 2015

© Renub Research

Page 10 of 18


Figure 6-14: Worldwide – Number of Doses of Polio Vaccines (Million Doses), 2005 – 2011 Figure 6-15: Worldwide – Forecast for Number of Doses of Polio Vaccines (Million Doses), 2012 – 2015 Figure 6-16: Worldwide – Immunization Coverage of Polio Vaccines (Million Doses), 2005 – 2011 Figure 6-17: Worldwide – Forecast for Immunization Coverage of Polio Vaccines (Million Doses), 2012 – 2015 Figure 6-18: Worldwide – Polio Vaccines Market (Million US$), 2005 – 2011 Figure 6-19: Worldwide – Forecast for Polio Vaccines Market (Million US$), 2012 – 2015 Figure 6-20: Worldwide – Number of Doses of DTP Vaccines (Million Doses), 2005 – 2011 Figure 6-21: Worldwide – Forecast for Number of Doses of DTP Vaccines (Million Doses), 2012 – 2015 Figure 6-22: Worldwide – Immunization Coverage of DTP Vaccines (Million Doses), 2005 – 2011 Figure 6-23: Worldwide – Forecast for Immunization Coverage of DTP Vaccines (Million Doses), 2012 – 2015 Figure 6-24: Worldwide – Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market (Million US$), 2005 – 2011 Figure 6-25: Worldwide – Forecast for Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market (Million US$), 2012 – 2015 Figure 6-26: Worldwide – Pneumococcal Vaccine Pipeline, 2000 – 2025 Figure 6-27: Worldwide – Number of Doses of Pneumococcal Vaccines (Million Doses), 2010 – 2011 Figure 6-28: Worldwide – Forecast for Number of Doses of Pneumococcal Vaccines (Million Doses), 2012 – 2015 Figure 6-29: Worldwide – Immunization Coverage of Pneumococcal Vaccines (Million Doses), 2010 – 2011 Figure 6-30: Worldwide – Forecast for Immunization Coverage of Pneumococcal Vaccines (Million Doses), 2012 – 2015 Figure 6-31: Worldwide – Pneumococcal Vaccines Market (Million US$), 2005 – 2011 Figure 6-32: Worldwide – Forecast for Pneumococcal Vaccines Market (Million US$), 2012 – 2015 Figure 6-33: Worldwide – Number of Doses of Rotavirus Vaccines (Million Doses), 2010 – 2011 Figure 6-34: Worldwide – Forecast for Number of Doses of Rotavirus Vaccines (Million Doses), 2012 – 2015 Figure 6-35: Worldwide – Immunization Coverage of Rotavirus Vaccines (Million Doses), 2010 – 2011 Figure 6-36: Worldwide – Forecast for Immunization Coverage of Rotavirus Vaccines (Million Doses), 2012 – 2015 Figure 6-37: Worldwide – Rotavirus Vaccine Market (Million US$), 2006 – 2011 Figure 6-38: Worldwide – Forecast for Rotavirus Vaccine Market (Million US$), 2012 – 2015 Figure 6-39: Worldwide – Number of Doses of Hepatitis Pediatric Vaccines (Million Doses), 2005 – 2011 Figure 6-40: Worldwide – Forecast for Number of Doses of Hepatitis Pediatric Vaccines (Million Doses), 2012 – 2015

© Renub Research

Page 11 of 18


Figure 6-41: Worldwide – Immunization Coverage of Hepatitis Pediatric Vaccines (Million Doses), 2005 – 2011 Figure 6-42: Worldwide – Forecast for Immunization Coverage of Hepatitis Pediatric Vaccines (Million Doses), 2012 – 2015 Figure 6-43: Worldwide – Hepatitis B Vaccine Introduction in High & Low-income countries, 1980 – 2010 Figure 6-44: Worldwide – Hepatitis Pediatric Vaccines Market (Million US$), 2005 – 2011 Figure 6-45: Worldwide – Forecast for Hepatitis Pediatric Vaccines Market (Million US$), 2012 – 2015 Figure 6-46: Worldwide – Number of Doses of Varicella Vaccines (Million Doses), 2005 – 2011 Figure 6-47: Worldwide – Forecast for Number of Doses of Varicella Vaccines (Million Doses), 2012 – 2015 Figure 6-48: Worldwide – Varicella Vaccines Market (Million US$), 2005 – 2011 Figure 6-49: Worldwide – Forecast for Varicella Vaccines Market (Million US$), 2012 – 2015 Figure 6-50: Worldwide – Other Pediatric Vaccines Market (Million US$), 2005 – 2011 Figure 6-51: Worldwide – Forecast for Other Pediatric Vaccines Market (Million US$), 2012 – 2015 Figure 7-1: Prices of Childhood Vaccines (US$), 2011 Figure 7-2: Reduction in Rotavirus Vaccine Prices (US$), May 2011 & April 2012 Figure 7-3: Increasing Number of GAVI Suppliers Based in Emerging Markets

© Renub Research

Page 12 of 18


List of Tables Table 4-1: Worldwide (Disease wise) – Pediatric Vaccines Market Share (Percent), 2006 – 2011 Table 4-2: Worldwide (Disease wise) – Forecast for Pediatric Vaccines Market Share (Percent), 2012 – 2015 Table 6-1: Worldwide (By Geographic Region) – Number of Measles Cases (Number), 2001 – 2011 Table 6-2: Worldwide (By Geographic Region) – Number of Mumps Cases (Number), 2001 – 2011 Table 6-3: Worldwide (By Geographic Region) – Number of Rubella Cases (Number), 2001 – 2011 Table 6-4: Worldwide (By Geographic Region) – Number of Haemophilus Influenzae Type B Meningitis Cases (Number), 2001 – 2011 Table 6-5: Worldwide (By Geographic Region) – Number of Polio Cases (Number), 2001 – 2011 Table 6-6: Worldwide (By Geographic Region) – Number of Diphtheria Cases (Number), 2001 – 2011 Table 6-7: Worldwide (By Geographic Region) – Number of nTetanus Cases (Number), 2001 – 2011 Table 6-8: Worldwide (By Geographic Region) – Number of tTetanus Cases (Number), 2001 – 2011 Table 6-9: Worldwide (By Geographic Region) – Number of Pertusis Cases (Number), 2001 – 2011 Table 6-10: Worldwide (By Geographic Region) – Pneumococcal Cases & Death in Children Under 5 Years of Age (Number), 2000 Table 6-11: Worldwide (By Geographic Region) – WHO Coordinated Rotavirus Surveillance (Number), 2008 – 2009 Table 6-12: Worldwide (By Geographic Region) – WHO Coordinated Rotavirus Surveillance Positive Cases (Number & Percent), 2009 Table 7-1: Worldwide – Total Future Deaths Averted through Vaccination (Million), 2011 – 2020 Table 7-2: Goal-Level Indicators, 2015 & 2020

© Renub Research

Page 13 of 18


Related Reports Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A Western Europe (EU-16) In Vitro Diagnostics Market Report & Forecast (2012 – 2015) Asia Medical Tourism Analysis and Forecast to 2015 Clinical Chemistry Market Report & Forecast (2012 – 2015): Global Analysis Hepatitis C (HCV) Market Forecast & Drugs Pipeline Analysis to 2016 Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast Genetic Testing Market and Forecast - Global Analysis 2010 – 2015 USA Cardiovascular Devices Market Trends and Forecast (2010 – 2015) Global Osteoporosis Market & Drugs Analysis 2010 – 2015 Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 – 2015) Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs Analysis Personalized Medicine Market (2010 - 2015) - By Segments, Technologies, Opportunities, Challenges & Future Forecast

© Renub Research

Page 14 of 18


Our Partial List of Clients

Redbus

Bain

Becton Dickinson

WAKE Technology Services, Inc.

Pfizer

PSS World Medical

Intercell

Relypsa

Sanofi Pasteur

C&K components

Stanford Burgess

Konkuk University

Pequot Capital

Resonetics

DMI

Samsung

Transgene S.A.

SEKISUI MEDICAL CO. LTD.

ixia communications

Plentyoffish Media INC

Toyota Tsusho Amercia Inc.

Arthur D Little Gmbh

National Health Research Institutes

Morgan Stanley

Abbott Diabetes Care

Takeda Pharmaceutical Corporation

Corning Incorporated - Life Sciences

Hokkai School of Commerce

L.E.K. Consulting GmbH

Ministry of Manpower Singapore

Syntiron

GenOmind, LLC.

MediVas LLC

Goldman Sachs & Co

Credit Suisse

NTT Advanced Technology

Dune Medical

Tokyo Womens Medical University

QIAGEN

The Chemo-Sero-Therapeutic Research

Inje University

Trade Council of Iceland

Mapp Biopharmaceutical

Jpmorgan, Ets Trading

Institute for Information Industry

GE Healthcare IT

NorDiag ASA

ixia communications

Š Renub Research Rep e Inv Medicas SA de Innogenetics

Page 15 of 18


Order Form Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780 Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to info@renub.com

Format Report Title: Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis

Single User (Email from Publisher)

Hard Copy (Mail Delivery)

CD – Rom (Mail Delivery)

Global Site License (Multiple User License)

US$ 1,400

US$ 1,550

US$ 1,500

US$ 2,200

For ordering this report: Three easy ways to place your order: 1) Order online by Credit Card (Visa, MasterCard, etc.): http://www.renub.com/report/pediatric-vaccines-market-doses-immunization-cases-andforecast-worldwide-analysis-86 2) Order by Wire Transfer: http://www.renub.com/report/wiretransfer.aspx?id=86&pid=1325 To pay by Wire Transfer, please, fill in your contact details in the form below:

Š Renub Research

Page 16 of 18


Bank Details Account Name: Renub Research A/C No.: 109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code: IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi – 110001 India

Contact Information First Name:

Last Name:

Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message:

© Renub Research

Page 17 of 18


3) Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research A -116B Sector -27 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090 LinkedIn: http://www.linkedin.com/company/renub-research Twitter: http://twitter.com/RenubResearch

Š Renub Research

Page 18 of 18


Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis  

Renub Research (http://www.renub.com/report/pediatric-vaccines-market-doses-immunization-cases-and-forecast-worldwide-analysis-86) has annou...

Advertisement
Read more
Read more
Similar to
Popular now
Just for you